As of 2026-09-22, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.02 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Pharmadrug Inc is -450.19%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 450.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.02 - -0.02 | -0.02 | -450.19% |
| DDM - Stable | 0.13 - 0.57 | 0.35 | 6880.3% |
| DDM - Multi | 3.75 - 11.39 | 5.45 | 108909.2% |
| Market Cap (mil) | 0.67 |
| Beta | -2.27 |
| Outstanding shares (mil) | 134.21 |
| Enterprise Value (mil) | 2.23 |
| Market risk premium | 5.10% |
| Cost of Equity | 2.77% |
| Cost of Debt | 5.00% |
| WACC | 4.09% |